New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
09:12 EDTAFDA approves two Dako assays
Dako, an Agilent Technologies company, announced it has received approval from the FDA for the addition of Kadcyla in the labeling of two Dako companion diagnostic assays. Kadcyla is Genentech's new medicine for patients with HER2-positive metastatic breast cancer who have received prior treatment with Genentech's cancer medicine Herceptin and a taxane chemotherapy. The two assays are Dako's HercepTest and HER2 IQFISH pharmDx.
News For A From The Last 14 Days
Check below for free stories on A the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
11:01 EDTAAgilent signs co-marketing agreement with MRM Proteomics
Subscribe for More Information
July 17, 2014
06:20 EDTAAgilent initiated with a Neutral at Citigroup
Target $64.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use